Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cell Reports Methods|February 23, 2023
A universal MHCII technology platform to characterize antigen-specific CD4+ T cellsRohit Vyasamneni, Victoria Kohler, Binisha Karki, et al.
Science (New York, N.Y.)|January 18, 2022
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human seraAlexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, et al.
Cell Reports|August 1, 2023
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunityAlexander Muik, Bonny Gaby Lui, Jasmin Quandt, et al.
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.
Nature Genetics|March 24, 2020
DNA methylation disruption reshapes the hematopoietic differentiation landscapeFranco Izzo, Stanley C Lee, Asaf Poran, et al.
Cancer Cell|August 26, 2022
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancerMark M Awad, Ramaswamy Govindan, Kristen N Balogh, et al.
Immunity|September 10, 2019
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Cell|May 10, 2023
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infectionChristina M Arieta, Yushu Joy Xie, Daniel A Rothenberg, et al.
Cell|February 17, 2024
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus diseaseAdam Zuiani, Charles L Dulberger, Nilushi S De Silva, et al.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Pageof 3